Canada markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9900+0.0800 (+8.79%)
At close: 04:00PM EST
0.9989 +0.01 (+0.90%)
After hours: 05:58PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 19.76M
Enterprise Value 31.96M
Trailing P/E 2.83
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.82
Price/Book (mrq)5.40
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.05

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3-61.92%
S&P500 52-Week Change 3-16.16%
52 Week High 34.3400
52 Week Low 30.6800
50-Day Moving Average 30.9456
200-Day Moving Average 31.3502

Share Statistics

Avg Vol (3 month) 3145.21k
Avg Vol (10 day) 356.26k
Shares Outstanding 520.8M
Implied Shares Outstanding 6N/A
Float 816.55M
% Held by Insiders 115.42%
% Held by Institutions 110.00%
Shares Short (Nov 14, 2022) 496.97k
Short Ratio (Nov 14, 2022) 41.72
Short % of Float (Nov 14, 2022) 40.50%
Short % of Shares Outstanding (Nov 14, 2022) 40.47%
Shares Short (prior month Oct 13, 2022) 4208.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,086.39%

Management Effectiveness

Return on Assets (ttm)-101.84%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.87M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)-22.50%
Gross Profit (ttm)-35.4M
EBITDA -30.58M
Net Income Avi to Common (ttm)-32.79M
Diluted EPS (ttm)-3.2630
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.89M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)14.08M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.20
Book Value Per Share (mrq)-2.02

Cash Flow Statement

Operating Cash Flow (ttm)-24.3M
Levered Free Cash Flow (ttm)-14.19M